Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options.

Shankar A, Daw S.

Br J Haematol. 2012 Nov;159(3):288-98. doi: 10.1111/bjh.12055. Epub 2012 Sep 21. Review.

PMID:
22994199
2.

Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.

Goel A, Fan W, Patel AA, Devabhaktuni M, Grossbard ML.

Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):261-70. doi: 10.1016/j.clml.2014.01.006. Epub 2014 Feb 3. Review.

PMID:
24650975
3.

[Nodular lymphocyte-predominant Hodgkin lymphoma in children: clinical course, biology, and management].

Gorde-Grosjean S, Guimard G, Lambilliotte A, Coulomb-Lhermine A, Montravers F, Landman-Parker J.

Bull Cancer. 2014 Sep;101(9):881-90. doi: 10.1684/bdc.2014.2021. Review. French.

PMID:
25296072
4.

The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management.

Hawkes EA, Wotherspoon A, Cunningham D.

Leuk Lymphoma. 2012 Mar;53(3):354-61. doi: 10.3109/10428194.2011.608455. Epub 2011 Sep 19. Review.

PMID:
21812538
5.

Modern management of lymphocyte-predominant Hodgkin lymphoma.

Xing KH, Savage KJ.

Br J Haematol. 2013 May;161(3):316-29. doi: 10.1111/bjh.12244. Epub 2013 Feb 8. Review.

PMID:
23398605
6.

High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only.

van Grotel M, Lam KH, de Man R, Beishuizen A, Pieters R, van den Heuvel-Eibrink MM.

Leuk Lymphoma. 2006 Aug;47(8):1504-10.

PMID:
16966260
7.

Nodular lymphocyte-predominant Hodgkin lymphoma.

Fuchs M, Eichenauer DA, Nogová L, Diehl V, Engert A; German Hodgkin Study Group..

Curr Hematol Malig Rep. 2008 Jul;3(3):126-31. doi: 10.1007/s11899-008-0019-5.

PMID:
20425457
8.

Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)-clinicopathological features based on the data of two Hungarian lymphoma centres.

Illés A, Simon Z, Tóth E, Rosta A, Miltényi Z, Molnár Z.

Pathol Oncol Res. 2008 Dec;14(4):411-21. doi: 10.1007/s12253-008-9043-y. Epub 2008 Apr 23.

PMID:
18431694
9.

Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups.

Shankar AG, Roques G, Kirkwood AA, Lambilliotte A, Freund K, Leblanc T, Hayward J, Abbou S, Ramsay AD, Schmitt C, Gorde-Grosjean S, Pacquement H, Haouy S, Boudjemaa S, Aladjidi N, Hall GW, Landman-Parker J.

Br J Haematol. 2017 Apr;177(1):106-115. doi: 10.1111/bjh.14518. Epub 2017 Feb 21.

PMID:
28220934
10.

How I treat nodular lymphocyte predominant Hodgkin lymphoma.

Advani RH, Hoppe RT.

Blood. 2013 Dec 19;122(26):4182-8. doi: 10.1182/blood-2013-07-453241. Epub 2013 Nov 8.

11.

Nodular lymphocyte predominant Hodgkin lymphoma behaves as a distinct clinical entity with good outcome: evidence from 14-year follow-up in the West of Scotland Cancer Network.

Farrell K, McKay P, Leach M.

Leuk Lymphoma. 2011 Oct;52(10):1920-8. doi: 10.3109/10428194.2011.584993. Epub 2011 Jun 12.

PMID:
21663507
12.

Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.

Gerber NK, Atoria CL, Elkin EB, Yahalom J.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):76-83. doi: 10.1016/j.ijrobp.2015.02.012. Epub 2015 Mar 14.

13.

A 20-year population-based study on the epidemiology, clinical features, treatment, and outcome of nodular lymphocyte predominant Hodgkin lymphoma.

Strobbe L, Valke LL, Diets IJ, van den Brand M, Aben K, Raemaekers JM, Hebeda KM, van Krieken JH.

Ann Hematol. 2016 Feb;95(3):417-23. doi: 10.1007/s00277-015-2578-6. Epub 2016 Jan 5.

14.

Nodular lymphocyte-predominant Hodgkin lymphoma.

Savage KJ, Mottok A, Fanale M.

Semin Hematol. 2016 Jul;53(3):190-202. doi: 10.1053/j.seminhematol.2016.05.009. Epub 2016 May 13. Review.

PMID:
27496311
15.

Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.

Sohani AR, Jaffe ES, Harris NL, Ferry JA, Pittaluga S, Hasserjian RP.

Am J Surg Pathol. 2011 Nov;35(11):1666-78. doi: 10.1097/PAS.0b013e31822832de.

PMID:
21997687
16.

Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a report from the United Kingdom's Children's Cancer and Leukaemia Study Group.

Shankar AG, Kirkwood AA, Depani S, Bianchi E, Hayward J, Ramsay AD, Hall GW.

Br J Haematol. 2016 May;173(3):421-31. doi: 10.1111/bjh.13979. Epub 2016 Mar 21.

PMID:
26996288
17.

Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.

Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA.

Am J Surg Pathol. 2003 Oct;27(10):1346-56.

PMID:
14508396
18.

Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome.

Savage KJ, Skinnider B, Al-Mansour M, Sehn LH, Gascoyne RD, Connors JM.

Blood. 2011 Oct 27;118(17):4585-90. doi: 10.1182/blood-2011-07-365932. Epub 2011 Aug 26.

19.

Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.

Nogová L, Rudiger T, Engert A.

Hematology Am Soc Hematol Educ Program. 2006:266-72. Review.

PMID:
17124071
20.

Nodular lymphocyte-predominant hodgkin lymphoma.

Tsai HK, Mauch PM.

Semin Radiat Oncol. 2007 Jul;17(3):184-9. Review.

PMID:
17591565

Supplemental Content

Support Center